Log in

NASDAQ:PHIOPhio Pharmaceuticals Stock Price, Forecast & News

$2.67
+0.19 (+7.66 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.42
Now: $2.67
$3.12
50-Day Range
$2.19
MA: $2.38
$2.65
52-Week Range
$1.60
Now: $2.67
$21.96
Volume2.30 million shs
Average Volume783,958 shs
Market Capitalization$15.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29
Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin and eye. The company also develops Samcyprone, a topical formulation of the small molecule diphenylcyclopropenone that is in a Phase IIa clinical trial for the clearance of common warts; RXI-231, an sd-rxRNA compound targeting tyrosinase, as a cosmetic ingredient that may enhance the appearance of uneven skin tone and pigmentation; and RXI-185, an sd-rxRNA compound targeting collagenase, as a cosmetic ingredient that may improve the appearance of wrinkles or skin laxity. In addition, it develops RXI-109, a Phase I/II clinical trial that reduces the progression of retinal scarring. The company has collaborations with the Center for Cancer Immune Therapy; Gustave Roussy; Medigene AG; PCI Biotech; and Karolinska Institutet. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. The company was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PHIO
CUSIPN/A
CIKN/A
Phone508-767-3861

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20,000.00
Book Value$8.59 per share

Profitability

Net Income$-8,910,000.00

Miscellaneous

Employees9
Market Cap$15.43 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable
$2.67
+0.19 (+7.66 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PHIO News and Ratings via Email

Sign-up to receive the latest news and ratings for PHIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Phio Pharmaceuticals (NASDAQ:PHIO) Frequently Asked Questions

How has Phio Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Phio Pharmaceuticals' stock was trading at $2.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PHIO shares have decreased by 3.6% and is now trading at $2.67.
View which stocks have been most impacted by Coronavirus
.

When is Phio Pharmaceuticals' next earnings date?

Phio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Phio Pharmaceuticals
.

How were Phio Pharmaceuticals' earnings last quarter?

Phio Pharmaceuticals Corp (NASDAQ:PHIO) announced its earnings results on Tuesday, May, 12th. The company reported ($1.33) EPS for the quarter.
View Phio Pharmaceuticals' earnings history
.

Has Phio Pharmaceuticals been receiving favorable news coverage?

News coverage about PHIO stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Phio Pharmaceuticals earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Phio Pharmaceuticals
.

Are investors shorting Phio Pharmaceuticals?

Phio Pharmaceuticals saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 99,500 shares, a decline of 8.9% from the June 30th total of 109,200 shares. Based on an average trading volume of 1,420,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.7% of the company's shares are sold short.
View Phio Pharmaceuticals' Current Options Chain
.

Who are some of Phio Pharmaceuticals' key competitors?

What other stocks do shareholders of Phio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phio Pharmaceuticals investors own include General Motors (GM), General Mills (GIS), Ocugen (OCGN), Preferred Apartment Communities (APTS), BCE (BCE), Baidu (BIDU), Carnival (CCL), Delta Air Lines (DAL), DURECT (DRRX) and Eastman Chemical (EMN).

Who are Phio Pharmaceuticals' key executives?

Phio Pharmaceuticals' management team includes the following people:
  • Dr. Gerrit Dispersyn Ph.D., Dr. Med. Sc, Pres & CEO (Age 44)
  • Ms. Caitlin Kontulis, VP of Fin. & Admin. and Sec. (Age 33)

What is Phio Pharmaceuticals' stock symbol?

Phio Pharmaceuticals trades on the NASDAQ under the ticker symbol "PHIO."

Who are Phio Pharmaceuticals' major shareholders?

Phio Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional investors include Wedbush Securities Inc. (0.58%).

Which institutional investors are buying Phio Pharmaceuticals stock?

PHIO stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc..

How do I buy shares of Phio Pharmaceuticals?

Shares of PHIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Phio Pharmaceuticals' stock price today?

One share of PHIO stock can currently be purchased for approximately $2.67.

How big of a company is Phio Pharmaceuticals?

Phio Pharmaceuticals has a market capitalization of $15.43 million and generates $20,000.00 in revenue each year. The company earns $-8,910,000.00 in net income (profit) each year or ($19.33) on an earnings per share basis. Phio Pharmaceuticals employs 9 workers across the globe.

What is Phio Pharmaceuticals' official website?

The official website for Phio Pharmaceuticals is phiopharma.com.

How can I contact Phio Pharmaceuticals?

Phio Pharmaceuticals' mailing address is 257 SIMARANO DRIVE SUITE 101, MARLBOROUGH MA, 01752. The company can be reached via phone at 508-767-3861 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.